Beacon Pointe Advisors, LLC Selecta Biosciences Inc Transaction History

Beacon Pointe Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$1.33 - $2.6 $25,270 - $49,400	19,000 New	19,000 $31,000
Q2 2022 Aug 11, 2022	SELL	$0.67 - $1.4 $18,090 - $37,800	-27,000 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$1.23 - $3.31 $33,210 - $89,370	27,000 New	27,000 $33,000
Q4 2021 Feb 14, 2022	SELL	$2.89 - $4.43 $54,910 - $84,170	-19,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.62 $63,840 - $87,780	19,000 New	19,000 $79,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.